Jerrold Sendrow insider trades: Virpax Pharmaceuticals (VRPX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jerrold reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 24, 2022 | VRPX | ↑ Buy | 4,500 | $1.29 | $6K | Direct | May 26, 2022 (2d) |
| Nov 22, 2021 | VRPX | ↑ Buy | 3,900 | $3.92 | $15K | Direct | Nov 24, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jerrold Sendrow's insider trades
Jerrold Sendrow is a director at Virpax Pharmaceuticals (VRPX). Since Nov 22, 2021, Jerrold has reported 2 open-market purchases worth $21K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRPX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.